VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
This Quarter Return
+23.55%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$135M
AUM Growth
+$135M
(+86%)
Cap. Flow
+$51.4M
Cap. Flow
% of AUM
38.13%
Top 10 Holdings %
Top 10 Hldgs %
44.79%
Holding
161
New
7
Increased
113
Reduced
25
Closed
15
Top Buys
| 1 |
ETP
Energy Transfer Partners L.p.
ETP
|
$5.09M |
| 2 |
EEP
Enbridge Energy Partners
EEP
|
$3.39M |
| 3 |
WPZ
Williams Partners L.P.
WPZ
|
$3.33M |
| 4 |
Plains All American Pipeline
PAA
|
$3.25M |
| 5 |
OKS
Oneok Partners LP
OKS
|
$2.89M |
Top Sells
| 1 |
Targa Resources
TRGP
|
$615K |
| 2 |
XNPT
XENOPORT, INC.
XNPT
|
$458K |
| 3 |
Exelixis
EXEL
|
$314K |
| 4 |
MDVN
MEDIVATION, INC.
MDVN
|
$310K |
| 5 |
Theravance Biopharma
TBPH
|
$304K |
Sector Composition
| 1 | Energy | 64.18% |
| 2 | Healthcare | 25.09% |
| 3 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Western Midstream Partners
WES
$14.6B
| $788K | 0.58% |
20,602
+5,291
| +35% | +$202K |
|
|
KERX
27
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $613K | 0.45% |
92,536
-43,936
| -32% | -$291K |
|
|
SE
28
DELISTED
Spectra Energy Corp Wi
SE
| $597K | 0.44% |
16,311
+7,830
| +92% | +$287K |
|
29
Travere Therapeutics
TVTX
$1.75B
| $585K | 0.43% |
32,857
+4,223
| +15% | +$75.2K |
|
|
30
Exelixis
EXEL
$9.95B
| $580K | 0.43% |
74,230
-40,199
| -35% | -$314K |
|
31
Ionis Pharmaceuticals
IONS
$9.64B
| $567K | 0.42% |
24,345
+13,898
| +133% | +$324K |
|
|
SGEN
32
DELISTED
Seagen Inc. Common Stock
SGEN
| $565K | 0.42% |
13,991
-550
| -4% | -$22.2K |
|
33
Vanda Pharmaceuticals
VNDA
$279M
| $563K | 0.42% |
50,287
-16,734
| -25% | -$187K |
|
34
Ligand Pharmaceuticals
LGND
$3.25B
| $561K | 0.42% |
7,542
-1,343
| -15% | -$99.9K |
|
35
Ironwood Pharmaceuticals
IRWD
$201M
| $553K | 0.41% |
50,479
-13,744
| -21% | -$151K |
|
|
36
Theravance Biopharma
TBPH
$692M
| $552K | 0.41% |
24,323
-13,380
| -35% | -$304K |
|
|
ICPT
37
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $546K | 0.41% |
3,826
+2,291
| +149% | +$327K |
|
|
PDLI
38
DELISTED
PDL BioPharma, Inc.
PDLI
| $546K | 0.41% |
173,837
+15,203
| +10% | +$47.8K |
|
|
MDVN
39
DELISTED
MEDIVATION, INC.
MDVN
| $546K | 0.41% |
9,058
-5,139
| -36% | -$310K |
|
40
Incyte
INCY
$17B
| $545K | 0.4% |
6,820
+1,707
| +33% | +$136K |
|
41
Biogen
BIIB
$20.5B
| $544K | 0.4% |
2,251
+206
| +10% | +$49.8K |
|
42
Gilead Sciences
GILD
$140B
| $543K | 0.4% |
6,511
+701
| +12% | +$58.5K |
|
43
Amgen
AMGN
$153B
| $541K | 0.4% |
3,557
-87
| -2% | -$13.2K |
|
|
ACOR
44
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $539K | 0.4% |
176
+48
| +38% | +$147K |
|
45
United Therapeutics
UTHR
$17.7B
| $537K | 0.4% |
5,073
+1,404
| +38% | +$149K |
|
|
RPTP
46
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
| $535K | 0.4% |
99,654
-27,215
| -21% | -$146K |
|
|
CELG
47
DELISTED
Celgene Corp
CELG
| $531K | 0.39% |
5,386
+502
| +10% | +$49.5K |
|
48
Halozyme
HALO
$8.75B
| $529K | 0.39% |
61,274
+24,579
| +67% | +$212K |
|
|
ENLC
49
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $528K | 0.39% |
33,190
+15,939
| +92% | +$254K |
|
50
BioMarin Pharmaceuticals
BMRN
$11.3B
| $522K | 0.39% |
6,713
+811
| +14% | +$63.1K |
|